S. Azhagu Madhavan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. S. Azhagu Madhavan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Saveetha University | India

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. S. Azhagu Madhavan’s academic journey is rooted deeply in the life sciences, with a steadfast commitment to zoology and biotechnology. He completed his B.Sc., M.Sc., and Ph.D. at the prestigious A.V.V.M. Sri Pushpam College, affiliated with Bharathidasan University, Tamil Nadu, India. His academic curiosity led him from foundational studies in zoology and biotechnology to advanced research, culminating in a doctoral thesis titled “Elucidating the Pharmacological Effect of Costus Spicatus Rhizome Extract in Streptozotocin Induced Diabetic Albino Wistar Rats.” 🧪🧬 His early academic work also explored microbial biodiversity within earthworm guts, revealing his interest in both macro and micro life sciences.

🧑‍🔬 Professional Endeavors

With nearly five years of experience in academia and research, Dr. Madhavan has been shaping the minds of future scientists. He currently serves as an Assistant Professor at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai. Prior to this, he honed his research skills as a Research Associate at Global Scientific Research Services and as a Research Assistant at Harman Institute of Science Education and Research. His journey reflects a blend of academic rigor and practical experience, contributing meaningfully to the scientific community.

🔍 Contributions and Research Focus

Dr. Madhavan’s research encompasses a wide range of cutting-edge disciplines including pharmacology, phytochemistry, nanobiotechnology, pharmaceuticals, and agricultural entomology. His scholarly efforts have led to impactful discoveries, especially in the synthesis and application of bioactive compounds and nanomaterials. His work on silver nanoparticles, biomarkers in autoimmune and neurological disorders, and natural therapeutic agents stands out for its translational value in modern medicine. His diverse research interests continue to evolve with interdisciplinary collaborations.

🏆 Accolades and Recognition

Dr. Madhavan’s academic brilliance has not gone unnoticed. In 2020, he was honored with the International Young Scientist Award at the 7th International Scientist Awards on Engineering, Science, and Medicine by VDGOOD Professional Association. He has also been recognized at several national conferences for his innovative contributions and oral presentations, including awards for his early research on earthworm-associated microbiota. His invited talks and memberships in peer-reviewed scholarly publishing forums further validate his scientific excellence.

🌍 Impact and Influence

Dr. Madhavan has made a global impact through his research, with multiple Q1 journal publications in top-tier platforms like Elsevier, Springer, and the Royal Society of Chemistry. His work has contributed to our understanding of nanomedicine, immunology, forensic neuroscience, and plant-based bioactive therapies, gaining recognition from peers worldwide. His designs, patented under the Indian IPR system, including innovations like biosensors, UV chambers, and biodegradable delivery systems, are already making waves in health tech and agriculture.

🌟 Legacy and Future Contributions

Dr. Madhavan is poised to leave a lasting legacy in biomedical and biotechnological research. His future plans likely include expanding interdisciplinary research, mentoring young scientists, and driving innovation through sustainable and impactful science. His visionary approach—combining traditional knowledge with modern scientific tools like nanotechnology and pharmacogenomics—positions him as a transformative figure in life sciences. As a passionate educator and a dynamic researcher, his contributions will continue shaping science and society.

Publications


📄 Identification and characterization of silver nanoparticles from Erythrina indica and its antioxidant and Uropathogenic antimicrobial properties
Authors: Sivalingam, Azhagu Madhavan; Pandian, Arjun
Journal: Microbial Pathogenesis
Year: 2024


📄 Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
Authors: Sivalingam, Azhagu Madhavan; Sureshkumar, Darshitha D.
Journal: Molecular Neurobiology
Year: 2025


📄 Fungal pretreatment methods for organic wastes: advances and challenges in biomass valorization
Authors: Chaurasia, P.K.; Bharati, S.L.; Singh, S.; Sivalingam, A.M.; Shankar, S.; Mani, A.
Journal: RSC Sustainability
Year: 2025


📄 Antihyperglycemic Activity of Polyphenolic Metabolites and Biosynthesized Silver Nanoparticles from Pedalium murex: Characterization and Application of Antioxidant and Uropathogenic Antimicrobial Activities
Authors: Azhagu Madhavan Sivalingam; Arjun Pandian
Journal: Microbial Pathogenesis
Year: 2025


📄 Cerebellar pathology in forensic and clinical neuroscience
Authors: Azhagu Madhavan Sivalingam; Darshitha D. Sureshkumar; Vijayalakshmi Pandurangan
Journal: Ageing Research Reviews
Year: 2025


Assist Prof  Dr. Andreas Agathangelidis | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assist Prof  Dr. Andreas Agathangelidis | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

National and Kapodistrian University of Athens | Greece

Author Profile

Google Scholar

Early Academic Pursuits

Andreas Agathangelidis initiated his scientific journey at Thessaloniki's "G. Papanikolaou" hospital, delving into Chronic Lymphocytic Leukemia (CLL) and antigens for his diploma thesis. Subsequently, his Ph.D. at Aristotle University focused on immunogenetics in B-cell malignancies.

Professional Endeavors

Agathangelidis conducted groundbreaking studies during his Ph.D., notably refining CLL molecular classification using a sizable patient cohort. His postdoctoral research at San Raffaele Scientific Institute, Milan, explored CLL and Monoclonal B lymphocytosis (MBL) under Professor Paolo Ghia, broadening his expertise in advanced genetic methodologies.

Contributions and Research Focus

Significant contributions include expansive studies on CLL patients and the largest worldwide series on Mantle Lymphoma (MCL), emphasizing the role of antigens in disease progression. He conducted diverse immunoprofiling studies, exploring gene rearrangements and subtyping based on immunogenetics, oncogenetics, and immunophenotype integration.

Accolades and Recognition

Agathangelidis' pioneering research secured recognition, including fellowships from the HFRI Foundation and industry funding from Gilead Sciences. His leadership in the "CLLon" project, studying the B cell receptor's role in CLL and MBL development, represents a significant achievement in cancer genetics.

Impact and Influence

His work has significantly challenged prevailing views in disease mechanisms, refining classifications, and paving the way for targeted therapies for B-cell malignancies. The extensive studies he led have had a substantial impact on understanding disease ontogeny and the development of potential treatments.

Legacy and Future Contributions

Currently an Assistant Professor at the National and Kapodistrian University of Athens, Agathangelidis continues his research using advanced NGS technologies. His focus on elucidating the B cell receptor's role in CLL and MBL development through deep sequencing and bioinformatics is poised to bring forth notable advancements in cancer genetics and potential therapeutic avenues.

Notable Publications

Recurrent mutations refine prognosis in chronic lymphocytic leukemia 2014 (219)

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study 2015 (179)

Antigen receptor stereotypy in chronic lymphocytic leukemia 2016 (99)